Replies to post #94440 on Biotech Values

[DewDiligence]

FDA considers ending the Avandia vs. Actos safety study

Given the convoluted machinations the FDA is going through to ascertain what ought to be done with this trial—including consultation with members of Congress—it’s clear, IMO, that the decision will end up being political rather than scientific.